HC Wainwright Issues Positive Forecast for Aptose Biosciences (NASDAQ:APTO) Stock Price
Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) had its target price hoisted by HC Wainwright from $2.00 to $6.00 in a research report report published on Friday morning,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. Other research analysts also recently issued reports about the company. Alliance Global Partners raised Aptose […]
